Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy
AbstractAlthough small interfering RNA (siRNA) therapy has proven to be a specific and effective treatment in cells, the delivery of siRNA is a challenge for the applications of siRNA therapy. We present a degradable dextran with amine groups as an siRNA nano-carrier. In our nano-carrier, the amine groups are conjugated to the dextran platform through the acetal bonds, which are acid sensitive. Therefore this siRNA carrier is stable in neutral and basic conditions, while the amine groups can be cleaved and released from dextran platform under weak acid conditions (such as in endosomes). The cleavage and release of amine groups can reduce the toxicity of cationic polymer and enhance the transfection efficiency. We successfully applied this nano-carrier to deliver choline kinase (ChoK) siRNA for ChoK inhibition in cells. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 158 KB)
Share & Cite This Article
Chen, Z.; Krishnamachary, B.; Bhujwalla, Z.M. Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy. Nanomaterials 2016, 6, 34.
Chen Z, Krishnamachary B, Bhujwalla ZM. Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy. Nanomaterials. 2016; 6(2):34.Chicago/Turabian Style
Chen, Zhihang; Krishnamachary, Balaji; Bhujwalla, Zaver M. 2016. "Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy." Nanomaterials 6, no. 2: 34.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.